Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT01957956 · COMPLETED
Trial details
- NCT number
- NCT01957956
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-11
- Primary completion
- 2016-11-16
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.